Detalhe da pesquisa
1.
Survival Outcomes in Men with Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Prostate-Only versus Whole Pelvic Radiation Therapy.
J Urol
; 207(6): 1227-1235, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085038
2.
Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy Alone.
J Natl Compr Canc Netw
; 20(4): 343-350.e4, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35193114
4.
The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy.
Cureus
; 15(1): e34351, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36874706
5.
Remote Symptom Monitoring of Patients With Cancer Undergoing Radiation Therapy.
Cureus
; 14(9): e29734, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36324357
6.
Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer.
Brachytherapy
; 21(3): 317-324, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123889
7.
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy.
Brachytherapy
; 21(5): 617-625, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641370
8.
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer.
Clin Genitourin Cancer
; 20(2): 123-131, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086762
9.
Challenges and Opportunities for Radiation Oncology Residency Programs During the 2020-2021 Virtual Residency Match.
Int J Radiat Oncol Biol Phys
; 110(3): 919-921, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34089692